These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Active or passive immunization in unexplained recurrent miscarriage. Christiansen OB; Nielsen HS; Pedersen B J Reprod Immunol; 2004 Jun; 62(1-2):41-52. PubMed ID: 15288180 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin therapy in dermatologic disorders. Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136 [TBL] [Abstract][Full Text] [Related]
9. What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus. Aoyama Y J Dermatol; 2010 Mar; 37(3):239-45. PubMed ID: 20507387 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. Kazatchkine MD; Kaveri SV N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745 [No Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease. Czernik A Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786 [No Abstract] [Full Text] [Related]
12. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases. Blank M; Bashi T; Shoenfeld Y Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850 [TBL] [Abstract][Full Text] [Related]
14. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases. Hurez V; Kaveri SV; Kazatchkine MD J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Sapir T; Blank M; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction. Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Brenner T; Laub O; Souroujon MC Ann N Y Acad Sci; 2008; 1132():244-8. PubMed ID: 18567875 [TBL] [Abstract][Full Text] [Related]
17. 7th International Immunoglobulin Conference: Poster presentations. Warnatz K; Ballow M; Stangel M; Bril V Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805 [TBL] [Abstract][Full Text] [Related]
18. Plasma TNF-α levels are higher in early pregnancy in patients with secondary compared with primary recurrent miscarriage. Piosik ZM; Goegebeur Y; Klitkou L; Steffensen R; Christiansen OB Am J Reprod Immunol; 2013 Nov; 70(5):347-58. PubMed ID: 23656493 [TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. Achiron A; Margalit R; Hershkoviz R; Markovits D; Reshef T; Melamed E; Cohen IR; Lider O J Clin Invest; 1994 Feb; 93(2):600-5. PubMed ID: 8113397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]